[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Kociba, 1969 - Google Patents

Bovine plasma thromboplastin antecedent (Factor XI) deficiency

Kociba, 1969

View PDF
Document ID
5019370429095219336
Author
Kociba G
Publication year

External Links

Snippet

Plasma Thromboplastin Antecedent (PTA, Factor XI) deficiency is a familial hemorrhagic disease of man. This disease first described by Rosenthal~~-(1) in 1953, is characterized by a mild bleeding tendency with the apparent deficiency of PTA from the blood. The genetic …
Continue reading at etd.ohiolink.edu (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Similar Documents

Publication Publication Date Title
Kociba Bovine plasma thromboplastin antecedent (Factor XI) deficiency
Hougie et al. Haemophilia Bm: a new type of factor-IX deficiency
Jagadeeswaran et al. Analysis of blood coagulation in the zebrafish
Nilsson et al. Intrauterine death and circulating anticoagulant (“antithromboplastin”)
Gentry Comparative aspects of blood coagulation
Zahavi et al. Acquired “storage pool disease” of platelets associated with circulating antiplatelet antibodies
Schwarz et al. Low total protein S antigen but high protein S activity due to decreased C4b-binding protein in neonates
Kitchens Factor XI: a review of its biochemistry and deficiency
Soff et al. Familial multiple coagulation factor deficiencies
Triplett Laboratory diagnosis of von Willebrand's disease
Bithell et al. Variant of factor IX deficiency in female with 45, X Turner’s syndrome
Barrow et al. Blood coagulation factor VIII (antihemophilic factor): with comments on von Willebrand's disease and Christmas disease.
Crockett Jr et al. Hypoprothrombinemia: studies of a case of the idiopathic type and the effect of serum administration
Hodgkinson et al. Etiology and management of hypofibrinogenemia of pregnancy
Brinkhous Hemophilia
Massicotte et al. A comparative study of coagulation systems in newborn animals
Graham Biochemical genetics of blood coagulation
Gentry et al. Coagulation factor XI deficiency in Holstein cattle: expression and distribution of factor XI activity.
Whissell et al. Hemophilia in a woman
Yang et al. Maternal-fetal transport of vitamin K1 and its effects on coagulation in premature infants
DIDISHEIM Hageman factor deficiency (Hageman trait): case report and review of the literature
Ratnoff et al. Wasp sting anaphylaxis
Geor et al. Prekallikrein deficiency in a family of Belgian horses
Lewis et al. Effects of Epsilon Aminocaproic Acid on Coagulation and Fibrinolytic Mechanisms: Studies of epsilon aminocaproic acid therapy in cirrhotic patients without gross bleeding tendencies suggest that the low factor V levels found in liver disease are caused by decreased production, not by increased destruction
Ekelund et al. Fibrinolysis in human foetuses